Download White Paper: A novel bispecific antibody, HD105, targeting VEGF and Dll4, inhibits angiogenesis and tumor growth in vivo

In this white paper, Sang Hoon Lee of Hanhwa Biologics discusses angiogenesis and tumour growth in vivo. Vascular endothelial growth factor (VEGF) signaling pathway have always been the method of choice for cancer treatment. However, VEGF inhibitors alone can promote tumor invasion and metastasis by increasing intratumoral hypoxia as shown in some preclinical models. Emerging reports have shown that Delta-like-ligand 4 (Dll4) …

Download Presentation: Key strategies of successful partnering in Biosimilar – Hanhwa Biologics’ Persepective

At the last BioPharma Asia 2013, Paul coleman from Hanhwa Biologics  gave the following presentation entitled: Key strategies of successful partnering in Biosimilar – Hanhwa Biologics’ Persepective. Click here to download presentation This presentation covered: Biosimilar business as a newly emerging field in biopharmaceutical industry Financial commitment, lack of experience and uncertainty in biosimilar business Mitigating challenges via biosimilar partnering key …